Skip to main content

Eye-opening study into ultra-processed foods and your risk of heart problems

If chips, hot dogs, frozen meals and sugary drinks are part of your daily diet, there’s new research you should know about.

A report from the American College of Cardiology found people who eat more than nine servings of ultra-processed food a day are an average of 67% more likely to have a heart attack or stroke, or die from heart disease than people who eat one serving a day.

The study also found that with each daily serving, the risk of such an event goes up by more than 5%. Among Black Americans, each additional serving leads to an increase in risk of more than 6%.

Dr. Michele Arthurs, a lifestyle medicine physician with Kaiser Permanente, told WTOP that if you’re not sure what you’re eating is ultra-processed, just look at the label.

“You can see a long list of ingredients, many of which you may not be able to pronounce because they are additives or chemicals that are used for food preservation to increase shelf life,” she said.

These kinds of foods also tend to be loaded with sugar, salt and saturated fat.

“Our body, essentially, has to fight with them in order to kind of process them and get them through our system. And this leads to inflammation in the body,” Arthurs said.

She recognized that many people may find it tough to stop eating ultra-processed foods altogether. Instead, she recommends limiting how much you eat.

“It doesn’t mean you can’t have that ballpark hot dog,” Arthurs said, adding that cutting it in half and sharing it with someone was also an option.

Other strategies Arthurs recommends to reduce the consumption of ultra-processed foods include:

  • Eat a healthy meal before you head to an event, like a baseball game, where you know you’ll be exposed to a lot of ultra-processed foods.
  • If you like sugary drinks, try alternating with ones that have little or no sugar.
  • If you love snacking on chips, bring along an orange too, and eat the fruit before diving into the bag of chips.

The findings, based on data from more than 6,800 U.S. adults, is being presented at the ACC’s Annual Scientific Session on March 28-30 in New Orleans. They’re also published in the journal JACC Advances.

Tools to fight hantavirus show promise despite limited funding. Now researchers hope to continue

SANTIAGO, Chile (AP) — When a rare but deadly rodent-borne virus struck passengers on a cruise ship and seemed to be spreading, there were no treatments for those who fell ill and no vaccines to protect others. That was the case even though it wasn't a novel germ that the world had never seen before, like the virus that caused the coronavirus pandemic. It was a hantavirus, one of a family of viruses that have been known for decades and are thought to exist around the world. Teams of researchers, including in Chile, Argentina and the United States, have long been trying to find and develop drugs and vaccines. But because the viruses are relatively rare and don't spread easily between people, there hasn't been enough sustained investment by governments, global health groups, or drug companies to pay for the extensive safety and efficacy testing needed to make them available. Still, there have been some promising developments. Researchers on Wednesday published a hint that a drug used for an autoimmune disease may help hantavirus patients fight off the most deadly symptoms.
Read Next Story